Experts discuss roadmap for antimicrobial stewardship

Antimicrobial resistance is once again making headlines. Amid the global pandemic, multiple studies have demonstrated significant increases in antimicrobial use in the U.S., China, and in Europe, specifically in patients with COVID-19. This emphasizes the importance of optimizing antimicrobial use for not only this population but for all patients, now more than ever.

Frontline clinicians are confronted with many factors to consider when treating patients, especially those in acute care. It can be a challenge to find concise, yet in-depth high quality information at the point of care in one easy location to make more informed decisions about antibiotic use.

In under 30 minutes, Sarah Wieczorkiewicz, PharmD, BCIDP, BCPS, FIDSA, senior clinical content specialist and co-author of The Pharmacist's Guide to Antimicrobial Therapy and Stewardship, and frontline pharmacist Emily Heil, PharmD, BCIDP, BCPS, AQ ID, AAHIVP, coordinator of the Antimicrobial Stewardship Program at the University of Maryland Medical Center and associate professor at the University of Maryland share a roadmap to better antibiotics use and concrete examples of information ‘must-haves’ for healthcare providers.

Liz Tomsik, PharmD, senior director for reference content, and Bill Alvarez, PharmD, BCPS, Director of Content Harmonization at Wolters Kluwer, Health, moderate the discussion.